Anti-oxidant Promoting Cytokine LIF Enhances Neural Cell Survival During Ischemia
抗氧化促进细胞因子 LIF 增强缺血期间神经细胞的存活
基本信息
- 批准号:8536410
- 负责人:
- 金额:$ 21.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsAntioxidantsBehavioralBrainCell DeathCell SurvivalCerebral IschemiaCessation of lifeClinicalCulture MediaCultured CellsCytoprotectionDataEnzymesFDA approvedFemaleFutureGlucoseHealthHourInflammationIschemiaLaboratoriesLong-Term EffectsMediatingMiddle Cerebral Artery OcclusionModelingNeuronsOligodendrogliaOxidative StressOxygenPRDX3 peroxidasePathway interactionsPhosphotransferasesPropertyRattusRecoverySignal PathwaySignal TransductionSignaling MoleculeStrokeTestingTherapeuticTimeagedbasecell typeclinically relevantcytokinedeprivationextracellularin vitro Modelin vivoleukemia inhibitory factorleukemia inhibitory factor receptornerve injurynervous system disordernovelnovel therapeutic interventionoxidationperoxiredoxinprotective effectresearch studyresponsetreatment effect
项目摘要
DESCRIPTION (provided by applicant): The cytokine, leukemia inhibitory factor (LIF), has been shown to be a potential therapeutic molecule for neurological disorders, including stroke. While LIF has been shown to activate cellular survival pathways, exact mechanisms have yet to be elucidated. Our laboratory has shown that LIF protects cultured oligodendrocytes (OLs) from oxygen glucose deprivation (OGD). One of its mechanisms is by increasing the expression of antioxidant enzymes, metallothinein-3 (Mt3) and peroxiredoxin-4 (Prdx4), to reduce extracellular oxidative stress. The proposed experiments will elucidate the LIF signaling mechanisms leading to the increased expression of the Mt3 and Prdx4 to reduce oxidative stress. Our hypothesis is that LIF protects oligodendrocytes exposed to ischemic conditions via antioxidant signaling. This proposal will utilize an in vitro model of ischemia to define the signaling pathway responsible for
the protective and antioxidant effects of LIF. Moreover, we will expand on these results to determine in vivo whether delayed i.v. administration of LIF protects OLs in the rat brain from focal cerebral ischemia through increased antioxidant activity. Lastly we will test this delayed administration for its efficacy to enhance long-term behavioral recovery. This proposal will provide the data for additional animal studies to examine LIF as a potential therapeutic to widen the treatment window for stroke.
描述(由申请人提供):细胞因子白血病抑制因子(LIF)已被证明是神经系统疾病(包括卒中)的潜在治疗分子。虽然LIF已被证明激活细胞存活途径,但确切的机制尚未阐明。我们的实验室已经表明,LIF保护培养的少突胶质细胞(OLs)从氧葡萄糖剥夺(OGD)。其机制之一是通过增加抗氧化酶金属硫蛋白-3(Mt3)和过氧化物氧还蛋白-4(Prdx 4)的表达来减少细胞外氧化应激。拟议的实验将阐明LIF信号传导机制,导致Mt3和Prdx 4的表达增加,以减少氧化应激。我们的假设是,LIF保护暴露于缺血条件下的少突胶质细胞通过抗氧化信号。该提案将利用缺血的体外模型来定义负责以下的信号通路:
LIF的保护和抗氧化作用。此外,我们将扩大这些结果,以确定在体内是否延迟静脉注射LIF保护OL在大鼠脑局灶性脑缺血通过增加抗氧化活性。最后,我们将测试这种延迟给药对促进长期行为恢复的有效性。该提案将为其他动物研究提供数据,以检查LIF作为一种潜在的治疗方法,以扩大中风的治疗窗口。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Molecular and cellular immune responses to ischemic brain injury.
- DOI:10.1007/s12975-014-0349-7
- 发表时间:2014-10
- 期刊:
- 影响因子:6.9
- 作者:Seifert, Hilary A.;Pennypacker, Keith R.
- 通讯作者:Pennypacker, Keith R.
Leukemia inhibitor factor promotes functional recovery and oligodendrocyte survival in rat models of focal ischemia.
- DOI:10.1111/ejn.12675
- 发表时间:2014-10
- 期刊:
- 影响因子:0
- 作者:Rowe DD;Collier LA;Seifert HA;Chapman CB;Leonardo CC;Willing AE;Pennypacker KR
- 通讯作者:Pennypacker KR
Pro-inflammatory interferon gamma signaling is directly associated with stroke induced neurodegeneration.
- DOI:10.1007/s11481-014-9560-2
- 发表时间:2014-12
- 期刊:
- 影响因子:6.2
- 作者:Seifert, Hilary A.;Collier, Lisa A.;Chapman, Cortney B.;Benkovic, Stanley A.;Willing, Alison E.;Pennypacker, Keith R.
- 通讯作者:Pennypacker, Keith R.
QUANTITATIVE MORPHOLOGICAL AND MOLECULAR PATHOLOGY OF THE HUMAN THYMUS CORRELATE WITH INFANT CAUSE OF DEATH.
人类胸腺的定量形态学和分子病理学与婴儿死因相关。
- DOI:10.3727/194982414x13971392823398
- 发表时间:2014
- 期刊:
- 影响因子:0.5
- 作者:Lloyd,MarkC;Burke,Nancy;Kalantarpour,Fatemeh;Niesen,MelissaI;Hall,Aaron;Pennypacker,Keith;Citron,Bruce;Pick,ChaimG;Adams,Vernard;Das,Mahasweta;Mohapatra,Shyam;Cualing,Hernani;Blanck,George
- 通讯作者:Blanck,George
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Keith R Pennypacker其他文献
Neuroinflammation and MMPs: potential therapeutic targets in neonatal hypoxic-ischemic injury
- DOI:
10.1186/1742-2094-6-13 - 发表时间:
2009-01-01 - 期刊:
- 影响因子:10.100
- 作者:
Christopher C Leonardo;Keith R Pennypacker - 通讯作者:
Keith R Pennypacker
Keith R Pennypacker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Keith R Pennypacker', 18)}}的其他基金
Anti-Oxidant Promoting Cytokine LIF Enhances Neural Cell Survival During Ischemia
抗氧化促进细胞因子 LIF 增强缺血期间神经细胞的存活
- 批准号:
9268246 - 财政年份:2016
- 资助金额:
$ 21.64万 - 项目类别:
Anti-oxidant Promoting Cytokine LIF Enhances Neural Cell Survival During Ischemia
抗氧化促进细胞因子 LIF 增强缺血期间神经细胞的存活
- 批准号:
8442622 - 财政年份:2012
- 资助金额:
$ 21.64万 - 项目类别:
Expanding the therapeutic window for stroke treatment.
扩大中风治疗的治疗窗口。
- 批准号:
7526955 - 财政年份:2008
- 资助金额:
$ 21.64万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 21.64万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 21.64万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 21.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 21.64万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 21.64万 - 项目类别:
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 21.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 21.64万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 21.64万 - 项目类别:
Discovery Grants Program - Individual
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 21.64万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 21.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)